These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30220923)

  • 21. Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.
    Morse MA; Hochster H; Benson A
    Oncologist; 2020 Jan; 25(1):33-45. PubMed ID: 31383813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer under age 40: a different approach.
    Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
    Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
    Pagani O; Senkus E; Wood W; Colleoni M; Cufer T; Kyriakides S; Costa A; Winer EP; Cardoso F;
    J Natl Cancer Inst; 2010 Apr; 102(7):456-63. PubMed ID: 20220104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report.
    Nagasaki E; Kudo R; Tamura M; Hayashi K; Uwagawa T; Kijima Y; Nogi H; Takeyama H; Suzuki M; Nishikawa M; Yano S; Kobayashi T
    Breast Cancer; 2021 Sep; 28(5):1051-1061. PubMed ID: 33840010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer.
    Ruff SM; Brown ZJ; Pawlik TM
    Surg Oncol; 2023 Dec; 51():101993. PubMed ID: 37742544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review.
    Remon J; Menis J; Levy A; De Ruysscher DKM; Hendriks LEL
    Transl Lung Cancer Res; 2021 Jul; 10(7):3486-3502. PubMed ID: 34430382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?
    Steenbruggen TG; Linn SC; Rodenhuis S; Sonke GS
    Cureus; 2015 Dec; 7(12):e433. PubMed ID: 26848422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant immunotherapy in gastrointestinal cancers - The new standard of care?
    Petricevic B; Kabiljo J; Zirnbauer R; Walczak H; Laengle J; Bergmann M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):834-850. PubMed ID: 35671877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic-cell tumor vaccines.
    Rolinski J; Hus I
    Transplant Proc; 2010 Oct; 42(8):3306-8. PubMed ID: 20970677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
    Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
    Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution.
    Yegya-Raman N; Aisner J; Kim S; Sayan M; Li D; Langenfeld J; Patel M; Malhotra J; Jabbour SK
    Adv Radiat Oncol; 2019; 4(3):541-550. PubMed ID: 31360811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional Therapies for Primary and Metastatic Breast Cancer:
    Deipolyi AR; Ward RC; Riaz A; Vogl TJ; Simmons RM; Pieper CC; Bryce Y
    AJR Am J Roentgenol; 2024 Feb; 222(2):e2329454. PubMed ID: 37377360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy for Meningiomas.
    Wirsching HG; Weller M
    Adv Exp Med Biol; 2023; 1416():225-234. PubMed ID: 37432631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment in oligometastatic breast cancer.
    Vargas C; Maiz C; Navarro ME; Oddó D; Sánchez C; Bustos M; Camus M
    Ecancermedicalscience; 2019; 13():931. PubMed ID: 31281428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
    Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future.
    Parisi A; Porzio G; Ficorella C
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer.
    Mangaj A; Chopra S; Nout RA
    Indian J Med Res; 2021 Aug; 154(2):303-318. PubMed ID: 35295014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
    Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
    Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
    Greenberg PA; Hortobagyi GN; Smith TL; Ziegler LD; Frye DK; Buzdar AU
    J Clin Oncol; 1996 Aug; 14(8):2197-205. PubMed ID: 8708708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.